# FDA recall D-0576-2022

> **Dr. Reddy's Laboratories, Inc.** · Class III · drug recall initiated 2022-01-19.

## Product

Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-465-62

## Reason for recall

Failed stability specifications

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0576-2022
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-01-19
- **Report date:** 2022-03-02
- **Termination date:** 2022-12-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0576-2022

## Citation

> AI Analytics. FDA recall D-0576-2022. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/D-0576-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*